APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vaccines

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Selected research

Market Structure

Global Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17404486031 January 2026198 pages

Choose your research edition.

Industry ResearchVaccines Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.

This report provides an overview of the global Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaccines Segment by Company

GSK

Sanofi

Merck

Pfizer

Novartis(GSK)

CSL

MedImmune LLC

J&J(Crucell)

China National Biotec

Tiantan

Hualan

Kangtai

Hissen

Jintan

Vaccines Segment by Type

Recombinant Vaccines

Viral Vaccines

Polysaccharide Vaccines

Others

Vaccines Segment by Application

Rabies vaccine

Influenza vaccine

HPV vaccine

Hepatitis B

Hepatitis A

Leprosy vaccine

Polio vaccine

JE vaccine

Others

Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Vaccines Industry Trends Table 2. Vaccines Industry Drivers Table 3. Vaccines Industry Opportunities and Challenges Table 4. Vaccines Industry Restraints Table 5. Global Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Vaccines Sales by Manufacturers (K Pcs) & (2021-2026) Table 8. Global Vaccines Sales Market Share by Manufacturers Table 9. Global Vaccines Average Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 10. Global Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Vaccines Manufacturers, Product Type & Application Table 13. Global Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Recombinant Vaccines Table 17. Major Manufacturers of Viral Vaccines Table 18. Major Manufacturers of Polysaccharide Vaccines Table 19. Major Manufacturers of Others Table 20. Global Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 21. Global Vaccines Sales by Type (2021-2026) & (K Pcs) Table 22. Global Vaccines Sales by Type (2027-2032) & (K Pcs) Table 23. Global Vaccines Sales Market Share by Type (2021-2026) Table 24. Global Vaccines Sales Market Share by Type (2027-2032) Table 25. Global Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Pcs) Table 26. Global Vaccines Revenue by Type (2021-2026) & (K Pcs) Table 27. Global Vaccines Revenue by Type (2027-2032) & (K Pcs) Table 28. Global Vaccines Revenue Market Share by Type (2021-2026) Table 29. Global Vaccines Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Rabies vaccine Table 31. Major Manufacturers of Influenza vaccine Table 32. Major Manufacturers of HPV vaccine Table 33. Major Manufacturers of Hepatitis B Table 34. Major Manufacturers of Hepatitis A Table 35. Major Manufacturers of Leprosy vaccine Table 36. Major Manufacturers of Polio vaccine Table 37. Major Manufacturers of JE vaccine Table 38. Major Manufacturers of Others Table 39. Global Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 40. Global Vaccines Sales by Application (2021-2026) & (K Pcs) Table 41. Global Vaccines Sales by Application (2027-2032) & (K Pcs) Table 42. Global Vaccines Sales Market Share by Application (2021-2026) Table 43. Global Vaccines Sales Market Share by Application (2027-2032) Table 44. Global Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Pcs) Table 45. Global Vaccines Revenue by Application (2021-2026) & (K Pcs) Table 46. Global Vaccines Revenue by Application (2027-2032) & (K Pcs) Table 47. Global Vaccines Revenue Market Share by Application (2021-2026) Table 48. Global Vaccines Revenue Market Share by Application (2027-2032) Table 49. Global Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 50. Global Vaccines Sales by Region (2021-2026) & (K Pcs) Table 51. Global Vaccines Sales Market Share by Region (2021-2026) Table 52. Global Vaccines Sales Forecasted by Region (2027-2032) & (K Pcs) Table 53. Global Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 54. North America Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 55. North America Vaccines Sales by Country (2021-2026) & (K Pcs) Table 56. North America Vaccines Sales by Country (2027-2032) & (K Pcs) Table 57. Europe Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 58. Europe Vaccines Sales by Country (2021-2026) & (K Pcs) Table 59. Europe Vaccines Sales by Country (2027-2032) & (K Pcs) Table 60. Asia Pacific Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 61. Asia Pacific Vaccines Sales by Country (2021-2026) & (K Pcs) Table 62. Asia Pacific Vaccines Sales by Country (2027-2032) & (K Pcs) Table 63. South America, Middle East and Africa Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 64. South America, Middle East and Africa Vaccines Sales by Country (2021-2026) & (K Pcs) Table 65. South America, Middle East and Africa Vaccines Sales by Country (2027-2032) & (K Pcs) Table 66. Global Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 67. Global Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 68. Global Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 69. Global Vaccines Revenue Market Share by Region (2021-2026) Table 70. Global Vaccines Revenue Market Share by Region (2027-2032) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. GSK Vaccines Product Portfolio Table 75. GSK Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Sanofi Vaccines Product Portfolio Table 80. Sanofi Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Merck Vaccines Product Portfolio Table 85. Merck Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Pfizer Vaccines Product Portfolio Table 90. Pfizer Recent Development Table 91. Novartis(GSK) Company Information Table 92. Novartis(GSK) Business Overview Table 93. Novartis(GSK) Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Novartis(GSK) Vaccines Product Portfolio Table 95. Novartis(GSK) Recent Development Table 96. CSL Company Information Table 97. CSL Business Overview Table 98. CSL Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. CSL Vaccines Product Portfolio Table 100. CSL Recent Development Table 101. MedImmune LLC Company Information Table 102. MedImmune LLC Business Overview Table 103. MedImmune LLC Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. MedImmune LLC Vaccines Product Portfolio Table 105. MedImmune LLC Recent Development Table 106. J&J(Crucell) Company Information Table 107. J&J(Crucell) Business Overview Table 108. J&J(Crucell) Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. J&J(Crucell) Vaccines Product Portfolio Table 110. J&J(Crucell) Recent Development Table 111. China National Biotec Company Information Table 112. China National Biotec Business Overview Table 113. China National Biotec Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. China National Biotec Vaccines Product Portfolio Table 115. China National Biotec Recent Development Table 116. Tiantan Company Information Table 117. Tiantan Business Overview Table 118. Tiantan Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Tiantan Vaccines Product Portfolio Table 120. Tiantan Recent Development Table 121. Hualan Company Information Table 122. Hualan Business Overview Table 123. Hualan Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Hualan Vaccines Product Portfolio Table 125. Hualan Recent Development Table 126. Kangtai Company Information Table 127. Kangtai Business Overview Table 128. Kangtai Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Kangtai Vaccines Product Portfolio Table 130. Kangtai Recent Development Table 131. Hissen Company Information Table 132. Hissen Business Overview Table 133. Hissen Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Hissen Vaccines Product Portfolio Table 135. Hissen Recent Development Table 136. Jintan Company Information Table 137. Jintan Business Overview Table 138. Jintan Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Jintan Vaccines Product Portfolio Table 140. Jintan Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Vaccines Distributors List Table 144. Vaccines Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Vaccines Product Image Figure 2. Global Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccines Sales (2021-2032) & (K Pcs) Figure 5. Global Vaccines Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Recombinant Vaccines Image Figure 9. Viral Vaccines Image Figure 10. Polysaccharide Vaccines Image Figure 11. Others Image Figure 12. Global Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 13. Global Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Vaccines Sales Market Share by Type (2021-2032) Figure 15. Global Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 16. Global Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Vaccines Revenue Market Share by Type (2021-2032) Figure 18. Rabies vaccine Image Figure 19. Influenza vaccine Image Figure 20. HPV vaccine Image Figure 21. Hepatitis B Image Figure 22. Hepatitis A Image Figure 23. Leprosy vaccine Image Figure 24. Polio vaccine Image Figure 25. JE vaccine Image Figure 26. Others Image Figure 27. Global Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 28. Global Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 29. Global Vaccines Sales Market Share by Application (2021-2032) Figure 30. Global Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 31. Global Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 32. Global Vaccines Revenue Market Share by Application (2021-2032) Figure 33. North America Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 34. North America Vaccines Sales Market Share by Country (2021-2032) Figure 35. U.S. Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 36. Canada Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 37. Mexico Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 38. Europe Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 39. Europe Vaccines Sales Market Share by Country (2021-2032) Figure 40. Germany Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 41. France Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 42. U.K. Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 43. Italy Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 44. Netherlands Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 45. Asia Pacific Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 46. Asia Pacific Vaccines Sales Market Share by Country (2021-2032) Figure 47. China Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 48. Japan Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 49. South Korea Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 50. Southeast Asia Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 51. India Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 52. Australia Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 53. South America, Middle East and Africa Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 54. South America, Middle East and Africa Vaccines Sales Market Share by Country (2021-2032) Figure 55. Brazil Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 56. South Africa Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 57. Saudi Arabia Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 58. Turkey Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 59. Argentina Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 60. UAE Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 61. Egypt Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 62. Chile Vaccines Sales and Growth Rate (2021-2032) & (K Pcs) Figure 63. Global Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Global Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 65. North America Vaccines Revenue (2021-2032) & (US$ Million) Figure 66. North America Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Europe Vaccines Revenue (2021-2032) & (US$ Million) Figure 68. Europe Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Asia-Pacific Vaccines Revenue (2021-2032) & (US$ Million) Figure 70. Asia-Pacific Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. South America, Middle East and Africa Vaccines Revenue (2021-2032) & (US$ Million) Figure 72. South America, Middle East and Africa Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 73. Vaccines Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Vaccines Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Viral Vaccines
  • Polysaccharide Vaccines
  • Others
Applications
  • Rabies vaccine
  • Influenza vaccine
  • HPV vaccine
  • Hepatitis B
  • Hepatitis A
  • Leprosy vaccine
  • Polio vaccine
  • JE vaccine
  • Others
Companies covered
  • GSK
  • Sanofi
  • Merck
  • Pfizer
  • Novartis(GSK)
  • CSL
  • MedImmune LLC
  • J&J(Crucell)
  • China National Biotec
  • Tiantan
  • Hualan
  • Kangtai
  • Hissen
  • Jintan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Vaccines Market Dynamics
  1. 2.1 Vaccines Industry Trends
  2. 2.2 Vaccines Industry Drivers
  3. 2.3 Vaccines Industry Opportunities and Challenges
  4. 2.4 Vaccines Industry Restraints
3 Vaccines Market by Manufacturers
  1. 3.1 Global Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vaccines Tier 1, Tier 2, and Tier 3
4 Vaccines Market by Type
  1. 4.1 Vaccines Type Introduction
  2. 4.1.1 Recombinant Vaccines
  3. 4.1.2 Viral Vaccines
  4. 4.1.3 Polysaccharide Vaccines
  5. 4.1.4 Others
  6. 4.2 Global Vaccines Sales by Type
  7. 4.2.1 Global Vaccines Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Vaccines Sales by Type (2021-2032)
  9. 4.2.3 Global Vaccines Sales Market Share by Type (2021-2032)
  10. 4.3 Global Vaccines Revenue by Type
  11. 4.3.1 Global Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Vaccines Revenue by Type (2021-2032)
  13. 4.3.3 Global Vaccines Revenue Market Share by Type (2021-2032)
5 Vaccines Market by Application
  1. 5.1 Vaccines Application Introduction
  2. 5.1.1 Rabies vaccine
  3. 5.1.2 Influenza vaccine
  4. 5.1.3 HPV vaccine
  5. 5.1.4 Hepatitis B
  6. 5.1.5 Hepatitis A
  7. 5.1.6 Leprosy vaccine
  8. 5.1.7 Polio vaccine
  9. 5.1.8 JE vaccine
  10. 5.1.9 Others
  11. 5.2 Global Vaccines Sales by Application
  12. 5.2.1 Global Vaccines Sales by Application (2021 VS 2025 VS 2032)
  13. 5.2.2 Global Vaccines Sales by Application (2021-2032)
  14. 5.2.3 Global Vaccines Sales Market Share by Application (2021-2032)
  15. 5.3 Global Vaccines Revenue by Application
  16. 5.3.1 Global Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  17. 5.3.2 Global Vaccines Revenue by Application (2021-2032)
  18. 5.3.3 Global Vaccines Revenue Market Share by Application (2021-2032)
6 Global Vaccines Sales by Region
  1. 6.1 Global Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Vaccines Revenue by Region
  1. 7.1 Global Vaccines Revenue by Region
  2. 7.1.1 Global Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Vaccines Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Vaccines Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Vaccines Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Vaccines Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Novartis(GSK)
  26. 8.5.1 Novartis(GSK) Company Information
  27. 8.5.2 Novartis(GSK) Business Overview
  28. 8.5.3 Novartis(GSK) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis(GSK) Vaccines Product Portfolio
  30. 8.5.5 Novartis(GSK) Recent Developments
  31. 8.6 CSL
  32. 8.6.1 CSL Company Information
  33. 8.6.2 CSL Business Overview
  34. 8.6.3 CSL Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CSL Vaccines Product Portfolio
  36. 8.6.5 CSL Recent Developments
  37. 8.7 MedImmune LLC
  38. 8.7.1 MedImmune LLC Company Information
  39. 8.7.2 MedImmune LLC Business Overview
  40. 8.7.3 MedImmune LLC Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MedImmune LLC Vaccines Product Portfolio
  42. 8.7.5 MedImmune LLC Recent Developments
  43. 8.8 J&J(Crucell)
  44. 8.8.1 J&J(Crucell) Company Information
  45. 8.8.2 J&J(Crucell) Business Overview
  46. 8.8.3 J&J(Crucell) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 J&J(Crucell) Vaccines Product Portfolio
  48. 8.8.5 J&J(Crucell) Recent Developments
  49. 8.9 China National Biotec
  50. 8.9.1 China National Biotec Company Information
  51. 8.9.2 China National Biotec Business Overview
  52. 8.9.3 China National Biotec Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 China National Biotec Vaccines Product Portfolio
  54. 8.9.5 China National Biotec Recent Developments
  55. 8.10 Tiantan
  56. 8.10.1 Tiantan Company Information
  57. 8.10.2 Tiantan Business Overview
  58. 8.10.3 Tiantan Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tiantan Vaccines Product Portfolio
  60. 8.10.5 Tiantan Recent Developments
  61. 8.11 Hualan
  62. 8.11.1 Hualan Company Information
  63. 8.11.2 Hualan Business Overview
  64. 8.11.3 Hualan Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hualan Vaccines Product Portfolio
  66. 8.11.5 Hualan Recent Developments
  67. 8.12 Kangtai
  68. 8.12.1 Kangtai Company Information
  69. 8.12.2 Kangtai Business Overview
  70. 8.12.3 Kangtai Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kangtai Vaccines Product Portfolio
  72. 8.12.5 Kangtai Recent Developments
  73. 8.13 Hissen
  74. 8.13.1 Hissen Company Information
  75. 8.13.2 Hissen Business Overview
  76. 8.13.3 Hissen Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hissen Vaccines Product Portfolio
  78. 8.13.5 Hissen Recent Developments
  79. 8.14 Jintan
  80. 8.14.1 Jintan Company Information
  81. 8.14.2 Jintan Business Overview
  82. 8.14.3 Jintan Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jintan Vaccines Product Portfolio
  84. 8.14.5 Jintan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vaccines Value Chain Analysis
  2. 9.1.1 Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vaccines Production Mode & Process
  6. 9.2 Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vaccines Distributors
  9. 9.2.3 Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst